Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs

Diaz-Rodriguez, E; Gandullo-Sanchez, L; Ocana, A; Pandiella, A

Pandiella, A (通讯作者),CSIC, IBSAL, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain.;Pandiella, A (通讯作者),CIBERONC, Salamanca 37007, Spain.

CANCERS, 2022; 14 (1):

Abstract

Simple Summary A proportion of breast tumors bear the oncogenic transmembrane tyrosine kinase protein HER2. Even though therapies that target HER2 hav......

Full Text Link